US FDA approves GSK's combo meningococcal vaccine
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Pfizer director Ronald E. Blaylock acquires $499,072 in stock
Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The transaction was valued at a total of $499,072, with each share priced at $25.65.
Direct Marketing News1d
Pfizer wins 2025 Super Bowl ad race
Pfizer clinches the top spot in the competitive 2025 Super Bowl ad race, promising groundbreaking visibility during the big ...
Jasper Therapeutics (JSPR) Gets a Buy from UBS
Jasper Therapeutics (JSPR – Research Report) received a Buy rating and a $38.00 price target from UBS analyst Trung Huynh today. The company’s ...
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE)
Shareholders of Pfizer may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) ...
Pfizer Inc. stock underperforms Tuesday when compared to competitors
Pfizer Inc. closed 19.06% short of its 52-week high of $31.54, which the company reached on July 30th.
Super Bowl 2025 Commercials and Trailers: All the Best Moments From the Big Game
Super Bowl LIX has now ended with the Philadelphia Eagles winning it all. However, they weren't the only winners as we were ...
Super Bowl commercials rely on comedy and nostalgia to avoid potential missteps
This year's Super Bowl commercials are going for laughs, with advertisers betting that viewers need a diversion from weighty ...